Skip to content

Inspection Record

Regen Suppliers LLC — FDA 483 Findings

US FDAInspected 2025-12-16Published 2026-10-26 8 findingsQuality unit oversightComplaint and recall handlingOther quality systemLabeling and packagingMaterial and supplier control

Inspectors Garrad R Poole · Laurissa S Flowers · Emily S McgannThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

There is no quality control unit.

2Complaint and recall handling

A system by which the distribution of each lot of drug product can be readily determined to facilitate its recall if necessary, has not been established.

3Other quality system

After the completion of the donor-eligibility determination, HCT/Ps were not accompanied with a statement whether the donor has been determined to be eligible or ineligible, based on the results of screening and testing.

4Complaint and recall handling

Procedures describing the handling of all written and oral complaints regarding a drug product are not established.

5Labeling and packaging

Drug product expiration dates do not appear on the labeling in the manner prescribed by regulations.

6Complaint and recall handling

The distribution system is deficient in that each lot of drug product cannot be readily determined to facilitate its recall if necessary.

7Material and supplier control

Procedures designed to assure that correct labeling and packaging materials are used for drug products are not written.

8Complaint and recall handling

Complaint procedures are deficient in that written complaint records are not maintained in a file designated for drug product complaints.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Regen Suppliers LLC company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.